Chronic myeloid leukemia: Reminiscences and dreams

Tariq I. Mughal, Jerald P. Radich, Michael W. Deininger, Jane F. Apperley, Timothy P. Hughes, Christine J. Harrison, Carlo Gambacorti-Passerini, Giuseppe Saglio, Jorge Cortes, George Q. Daley

Research output: Contribution to journalReview article

Abstract

With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman originally made seminal contributions to the use of autologous and allogeneic stem cell transplantation from the late 1970s onwards. Then, in collaboration with Brian Druker, he led efforts to develop ABL1 tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia in the late 1990s. He also led the global efforts to develop and harmonize methodology for molecular monitoring, and was an indefatigable organizer of international conferences. These conferences brought together clinicians and scientists, and accelerated the adoption of new therapies. The abundance of praise, tributes and testimonies expressed by many serve to illustrate the indelible impressions these two passionate and affable scholars made on so many people’s lives. This tribute provides an outline of the remarkable story of chronic myeloid leukemia, and in writing it, it is clear that the historical triumph of biomedical science over this leukemia cannot be considered without appreciating the work of both Janet Rowley and John Goldman.

Original languageEnglish (US)
Pages (from-to)541-558
Number of pages18
JournalHaematologica
Volume101
Issue number5
DOIs
StatePublished - Apr 30 2016
Externally publishedYes

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cytogenetics
Philadelphia Chromosome
Gene Fusion
Stem Cell Transplantation
Protein-Tyrosine Kinases
Anatomy
Leukemia
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Mughal, T. I., Radich, J. P., Deininger, M. W., Apperley, J. F., Hughes, T. P., Harrison, C. J., ... Daley, G. Q. (2016). Chronic myeloid leukemia: Reminiscences and dreams. Haematologica, 101(5), 541-558. https://doi.org/10.3324/haematol.2015.139337

Chronic myeloid leukemia : Reminiscences and dreams. / Mughal, Tariq I.; Radich, Jerald P.; Deininger, Michael W.; Apperley, Jane F.; Hughes, Timothy P.; Harrison, Christine J.; Gambacorti-Passerini, Carlo; Saglio, Giuseppe; Cortes, Jorge; Daley, George Q.

In: Haematologica, Vol. 101, No. 5, 30.04.2016, p. 541-558.

Research output: Contribution to journalReview article

Mughal, TI, Radich, JP, Deininger, MW, Apperley, JF, Hughes, TP, Harrison, CJ, Gambacorti-Passerini, C, Saglio, G, Cortes, J & Daley, GQ 2016, 'Chronic myeloid leukemia: Reminiscences and dreams', Haematologica, vol. 101, no. 5, pp. 541-558. https://doi.org/10.3324/haematol.2015.139337
Mughal TI, Radich JP, Deininger MW, Apperley JF, Hughes TP, Harrison CJ et al. Chronic myeloid leukemia: Reminiscences and dreams. Haematologica. 2016 Apr 30;101(5):541-558. https://doi.org/10.3324/haematol.2015.139337
Mughal, Tariq I. ; Radich, Jerald P. ; Deininger, Michael W. ; Apperley, Jane F. ; Hughes, Timothy P. ; Harrison, Christine J. ; Gambacorti-Passerini, Carlo ; Saglio, Giuseppe ; Cortes, Jorge ; Daley, George Q. / Chronic myeloid leukemia : Reminiscences and dreams. In: Haematologica. 2016 ; Vol. 101, No. 5. pp. 541-558.
@article{dfce560546584c77bf4e89a3bca9ede9,
title = "Chronic myeloid leukemia: Reminiscences and dreams",
abstract = "With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman originally made seminal contributions to the use of autologous and allogeneic stem cell transplantation from the late 1970s onwards. Then, in collaboration with Brian Druker, he led efforts to develop ABL1 tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia in the late 1990s. He also led the global efforts to develop and harmonize methodology for molecular monitoring, and was an indefatigable organizer of international conferences. These conferences brought together clinicians and scientists, and accelerated the adoption of new therapies. The abundance of praise, tributes and testimonies expressed by many serve to illustrate the indelible impressions these two passionate and affable scholars made on so many people’s lives. This tribute provides an outline of the remarkable story of chronic myeloid leukemia, and in writing it, it is clear that the historical triumph of biomedical science over this leukemia cannot be considered without appreciating the work of both Janet Rowley and John Goldman.",
author = "Mughal, {Tariq I.} and Radich, {Jerald P.} and Deininger, {Michael W.} and Apperley, {Jane F.} and Hughes, {Timothy P.} and Harrison, {Christine J.} and Carlo Gambacorti-Passerini and Giuseppe Saglio and Jorge Cortes and Daley, {George Q.}",
year = "2016",
month = "4",
day = "30",
doi = "10.3324/haematol.2015.139337",
language = "English (US)",
volume = "101",
pages = "541--558",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "5",

}

TY - JOUR

T1 - Chronic myeloid leukemia

T2 - Reminiscences and dreams

AU - Mughal, Tariq I.

AU - Radich, Jerald P.

AU - Deininger, Michael W.

AU - Apperley, Jane F.

AU - Hughes, Timothy P.

AU - Harrison, Christine J.

AU - Gambacorti-Passerini, Carlo

AU - Saglio, Giuseppe

AU - Cortes, Jorge

AU - Daley, George Q.

PY - 2016/4/30

Y1 - 2016/4/30

N2 - With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman originally made seminal contributions to the use of autologous and allogeneic stem cell transplantation from the late 1970s onwards. Then, in collaboration with Brian Druker, he led efforts to develop ABL1 tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia in the late 1990s. He also led the global efforts to develop and harmonize methodology for molecular monitoring, and was an indefatigable organizer of international conferences. These conferences brought together clinicians and scientists, and accelerated the adoption of new therapies. The abundance of praise, tributes and testimonies expressed by many serve to illustrate the indelible impressions these two passionate and affable scholars made on so many people’s lives. This tribute provides an outline of the remarkable story of chronic myeloid leukemia, and in writing it, it is clear that the historical triumph of biomedical science over this leukemia cannot be considered without appreciating the work of both Janet Rowley and John Goldman.

AB - With the deaths of Janet Rowley and John Goldman in December 2013, the world lost two pioneers in the field of chronic myeloid leukemia. In 1973, Janet Rowley, unraveled the cytogenetic anatomy of the Philadelphia chromosome, which subsequently led to the identification of the BCR-ABL1 fusion gene and its principal pathogenetic role in the development of chronic myeloid leukemia. This work was also of major importance to support the idea that cytogenetic changes were drivers of leukemogenesis. John Goldman originally made seminal contributions to the use of autologous and allogeneic stem cell transplantation from the late 1970s onwards. Then, in collaboration with Brian Druker, he led efforts to develop ABL1 tyrosine kinase inhibitors for the treatment of patients with chronic myeloid leukemia in the late 1990s. He also led the global efforts to develop and harmonize methodology for molecular monitoring, and was an indefatigable organizer of international conferences. These conferences brought together clinicians and scientists, and accelerated the adoption of new therapies. The abundance of praise, tributes and testimonies expressed by many serve to illustrate the indelible impressions these two passionate and affable scholars made on so many people’s lives. This tribute provides an outline of the remarkable story of chronic myeloid leukemia, and in writing it, it is clear that the historical triumph of biomedical science over this leukemia cannot be considered without appreciating the work of both Janet Rowley and John Goldman.

UR - http://www.scopus.com/inward/record.url?scp=84964777739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964777739&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.139337

DO - 10.3324/haematol.2015.139337

M3 - Review article

C2 - 27132280

AN - SCOPUS:84964777739

VL - 101

SP - 541

EP - 558

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 5

ER -